These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21681752)

  • 41. Amorphization within the tablet: Using microwave irradiation to form a glass solution in situ.
    Doreth M; Hussein MA; Priemel PA; Grohganz H; Holm R; Lopez de Diego H; Rades T; Löbmann K
    Int J Pharm; 2017 Mar; 519(1-2):343-351. PubMed ID: 28115260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemometric Model Development and Comparison of Raman and (13)C Solid-State Nuclear Magnetic Resonance-Chemometric Methods for Quantification of Crystalline/Amorphous Warfarin Sodium Fraction in the Formulations.
    Rahman Z; Mohammad A; Akhtar S; Siddiqui A; Korang-Yeboah M; Khan MA
    J Pharm Sci; 2015 Aug; 104(8):2550-8. PubMed ID: 26096869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures.
    Szczurek J; Rams-Baron M; Knapik-Kowalczuk J; Antosik A; Szafraniec J; Jamróz W; Dulski M; Jachowicz R; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1071-1081. PubMed ID: 28231007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
    Tian Y; Jones DS; Andrews GP
    Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monitoring the Dissolution Mechanisms of Amorphous Bicalutamide Solid Dispersions via Real-Time Raman Mapping.
    Tres F; Patient JD; Williams PM; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
    Mol Pharm; 2015 May; 12(5):1512-22. PubMed ID: 25872658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring of multiple solvent induced form changes during high shear wet granulation and drying processes using online Raman spectroscopy.
    Reddy JP; Jones JW; Wray PS; Dennis AB; Brown J; Timmins P
    Int J Pharm; 2018 Apr; 541(1-2):253-260. PubMed ID: 29481947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microfibrous Solid Dispersions of Poorly Water-Soluble Drugs Produced via Centrifugal Spinning: Unexpected Dissolution Behavior on Recrystallization.
    Marano S; Barker SA; Raimi-Abraham BT; Missaghi S; Rajabi-Siahboomi A; Aliev AE; Craig DQM
    Mol Pharm; 2017 May; 14(5):1666-1680. PubMed ID: 28296409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.
    Marsac PJ; Konno H; Rumondor AC; Taylor LS
    Pharm Res; 2008 Mar; 25(3):647-56. PubMed ID: 17846870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.
    Hausman DS; Cambron RT; Sakr A
    Int J Pharm; 2005 Aug; 299(1-2):19-33. PubMed ID: 15979262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approach.
    Petzoldt C; Bley O; Byard SJ; Andert D; Baumgartner B; Nagel N; Tappertzhofen C; Feth MP
    Eur J Pharm Biopharm; 2014 Apr; 86(3):337-50. PubMed ID: 24075979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
    Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Physical Stability of Felodipine and Its Recrystallization from an Amorphous Solid Dispersion Studied by NMR Relaxometry.
    Pajzderska A; Mielcarek J; Wąsicki J
    AAPS PharmSciTech; 2022 Mar; 23(4):93. PubMed ID: 35314906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms.
    Findlay WP; Bugay DE
    J Pharm Biomed Anal; 1998 Feb; 16(6):921-30. PubMed ID: 9547695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets.
    Xie Y; Tao W; Morrison H; Chiu R; Jona J; Fang J; Cauchon N
    Int J Pharm; 2008 Oct; 362(1-2):29-36. PubMed ID: 18588963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
    Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
    Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amorphous drug-PVP dispersions: application of theoretical, thermal and spectroscopic analytical techniques to the study of a molecule with intermolecular bonds in both the crystalline and pure amorphous state.
    Tobyn M; Brown J; Dennis AB; Fakes M; Gao Q; Gamble J; Khimyak YZ; McGeorge G; Patel C; Sinclair W; Timmins P; Yin S
    J Pharm Sci; 2009 Sep; 98(9):3456-68. PubMed ID: 19603506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formation, physical stability, and quantification of process-induced disorder in cryomilled samples of a model polymorphic drug.
    Hu Y; Macfhionnghaile P; Caron V; Tajber L; Healy AM; Erxleben A; McArdle P
    J Pharm Sci; 2013 Jan; 102(1):93-103. PubMed ID: 23047833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.